69614 Federal Register / Vol. 69, No. 229 / Tuesday, November 30, 2004 / Notices 

and other financial or credit institutions 

that are subject to examination and 

supervision in their capacity as lending 

institutions by an agency of the United 

States or of the State in which the 

lender has its principal place of 

business, obtained by participants for 

the following: 

• Undergraduate, graduate, and 

health professional school tuition 

expenses; 

• Other reasonable educational 

expenses required by the school(s) 

attended, including fees, books, 

supplies, educational equipment and 

materials, and laboratory expenses; and

• Reasonable living expenses, 

including the cost of room and board, 

transportation and commuting costs, 

and other living expenses as determined 

by the Secretary. 

Repayments are made directly to 

lenders, following receipt of (1) the 

Principal Investigator, Program Director, 

or Research Supervisor’s verification of 

completion of the prior period of 

research, and (2) lender verification of 

the crediting of prior loan repayments, 

including the resulting account balances 

and current account status. The NIH 

will repay loans in the following order, 

unless the Secretary determines that 

significant savings would result from a 

different order of priority: 

1. Loans guaranteed by the U.S. 

Department of Health and Human 

Services: 

• Health Education Assistance Loan 

(HEAL); 

• Health Professions Student Loan 

(HPSL); 

• Loans for Disadvantaged Students 

(LDS); and 

• Nursing Student Loan Program 

(NSL); 

2. Loans guaranteed by the U.S. 

Department of Education: 

• Direct Subsidized Stafford Loan; 

• Direct Unsubsidized Stafford Loan; 

• Direct Consolidation Loan; 

• Perkins Loan; 

• FFEL Subsidized Stafford Loan; 

• FFEL Unsubsidized Stafford Loan; 

and 

• FFEL Consolidation Loan; 

3. Loans made or guaranteed by a 

State, the District of Columbia, the 

Commonwealth of Puerto Rico, or a 

territory or possession of the United 

States; 

4. Loans made by academic 

institutions; and 

5. Private (‘‘Alternative’’) Educational 

Loans: 

• MEDLOANS; and 

• Private (non-guaranteed) 

Consolidation Loans. 

The following loans are NOT 

repayable under the Loan Repayment 

Program for Health Disparities Research: 

1. Loans not obtained from a U.S. or 

other government entity, academic 

institution, or a commercial or other 

chartered U.S. lending institution such 

as loans from friends, relatives, or other 

individuals, and non-educational loans, 

such as home equity loans; 

2. Loans for which contemporaneous 

documentation (current account 

statement, and promissory note or 

lender disclosure statement) is not 

available; 

3. Loans that have been consolidated 

with loans of other individuals, such as 

a spouse or child; 

4. Loans or portions of loans obtained 

for educational or living expenses, 

which exceed a reasonable level, as 

determined by the standard school 

budget for the year in which the loan 

was made, and are not determined by 

the LRP to be reasonable based on 

additional contemporaneous 

documentation provided by the 

applicant; 

5. Loans, financial debts, or service 

obligations incurred under the following 

programs, or other programs that incur 

a service obligation that converts to a 

loan on failure to satisfy the service 

obligation: 

• Armed Forces (Army, Navy, or Air 

Force) Health Professions Scholarship 

Program; 

• Indian Health Service (IHS) 

Scholarship Program; 

• National Institutes of Health 

Undergraduate Scholarship Program 

(UGSP); 

• National Research Service Award 

(NRSA) Program; 

• Physicians Shortage Area 

Scholarship Program (Federal or State); 

• Primary Care Loan (PCL) Program; 

and 

• Public Health Service (PHS) and 

National Health Service Corps (NHSC) 

Scholarship Program; 

6. Delinquent loans, loans in default, 

or loans not current in their payment 

schedule; 

7. PLUS Loans; 

8. Loans that have been paid in full; 

and 

9. Loans obtained after the execution 

of the NIH Loan Repayment Program 

Contract (e.g., promissory note signed 

after the LRP contract has been 

awarded) (this provision does not apply 

to qualifying loan consolidations). 

Before the commencement of loan 

repayment, or during lapses in loan 

repayments due to NIH administrative 

complications, Leave Without Pay 

(LWOP), or a break in service, LRP 

participants are wholly responsible for 

making payments or other arrangements 

that maintain loans current, such that 

increases in either principal or interest 

do not occur. The LRP contract period 

will not be modified or extended as a 

result of LWOP or a break in service. 

Penalties assessed participants as a 

result of NIH administrative 

complications to maintain a current 

payment status may not be considered 

for reimbursement. 

LRP payments are NOT retroactive. 

Loan repayment for fiscal year 2005 will 

commence after a loan repayment 

contract has been executed, which is 

expected to be no earlier than July 2005. 

This program is not subject to the 

provisions of Executive Order 12372, 

Intergovernmental Review of Federal 

Programs. 

This program is subject to OMB 

clearance under the requirements of the 

Paperwork Reduction Act of 1995. The 

OMB approval of the information 

collection associated with the HDR–LRP 

expires on December 31, 2004. The 

Catalog of Federal Domestic Assistance 

number for the Health Disparities LRP is 

93.307.

Dated: November 19, 2004. 

Elias A. Zerhouni, 

Director, NIH.

[FR Doc. 04–26366 Filed 11–29–04; 8:45 am] 

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Paul 

Calabresi Award for Clinical Oncology PAR–

04–096. 

Date: January 20, 2005. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Federal Register / Vol. 69, No. 229 / Tuesday, November 30, 2004 / Notices 69615

Contact Person: Robert Bird, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, National 

Cancer Institute, National Institutes of 

Health, 6116 Executive Blvd., MSC 8328, 

Room 8113, Bethesda, MD 20892–8328, 301–

496–7978, birdr@mail.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: November 22, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26364 Filed 11–29–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Director’s 

Consumer Liaison Group. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: National Cancer 

Institute Director’s Consumer Liaison Group. 

Date: December 14, 2004. 

Time: 3 p.m. to 5 p.m. 

Agenda: Update on NCI Listens and Learns 

Operations; Update on NCI Listens and 

Learns Summit and Discussion; Update on 

NCI Promotion Efforts; Update on NCI 

Listens and Learns Evaluation Plan and 

Discussion; Public Comment; Next Steps. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Nancy Caliman, Executive 

Secretary, Office of Liaison Activities, 

National Institutes of Health, National Cancer 

Institute, 6116 Executive Boulevard, Suite 

220, MSC8324, Bethesda, MD 20892, (301) 

496–0307, calimann@mail.nih.gov.

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/dclg/dclg.htm,

where an agenda and any additional 

information for the meeting will be posted 

when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)

Dated: November 22, 2004. 

LaVerne Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26365 Filed 11–29–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel ZAA1 EE (02)—Application 

Reviews. 

Date: November 29, 2004. 

Time: 9 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The River Inn, 924 25th Street, NW., 

Washington, DC 20037. 

Contact Person: Dorita Sewell, PhD, 

Scientific Review Administrator, National 

Institutes of Health, National Institute on 

Alcohol Abuse and Alcoholism, Office of 

Extramural Research, 5635 Fishers Lane, 

Bethesda, MD 20892–9304, (301) 443–2890, 

dsewell@mail.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel ZAA1 HH (03)—Application 

Reviews. 

Date: December 3, 2004. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The River Inn, 924 25th Street, NW., 

Washington, DC 20037. 

Contact Person: Jeffrey I. Toward, PhD, 

Scientific Review Administrator, National 

Institutes of Health, National Institute on 

Alcohol Abuse and Alcoholism, Extramural 

Project Review Branch, OSA, 5635 Fishers 

Lane, Bethesda, MD 20892–9304, (301) 435–

5337, jtoward@mail.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel ZAA1 HH (07)—U18 

Cooperative Agreement Applications. 

Date: December 6, 2004. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: National Institutes of Health, Fishers 

Building—MSC 9304, 5635 Fishers Lane, 

Suite 3033, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Jeffrey I. Toward, PhD, 

Scientific Review Administrator, National 

Institutes of Health, National Institute on 

Alcohol Abuse and Alcoholism, Extramural 

Project Review Branch, OSA, 5635 Fishers 

Lane, Bethesda, MD 20892–9304, (301) 435–

5337, jtoward@mail.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS)

Dated: November 22, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–26360 Filed 11–29–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose